Paxlovid speeds COVID-19 recovery but does not reduce hospital admissions Across two trials, more than 4,000 patients were randomised to receive usual care or Paxlovid (nirmatrelvir and ritonavir; Pfizer) within three or four days of symptom onset.…
SMRs cut prescribing of potentially inappropriate medicines by up to 40% Researchers studying data from 635,698 patients discovered that non-steroidal anti-inflammatory drugs were the most commonly stopped prescription following a structured medication review.…
Royal College of Pharmacy appoints head of professional standards and patient safety The College has also announced three more additions to its trustee board.…
Pharmacy regulator publishes AI position statement The General Pharmaceutical Council said that pharmacy professionals should remember that they remain “personally accountable for their professional practice, even when AI is being used”.…
NICE recommends take-at-home tablet for chronic lymphocytic leukaemia Pirtobrutinib has been approved for patients with recurrent chronic lymphocytic leukaemia — who have already been given a covalent BTK inhibitor (BTKi) — and for whom further covalent BTKi treatment is not suitable.…
Government is reviewing enforcement mechanisms on medicines shortages reporting In its response to a House of Lords Public Services Committee report on medicines security, the Department of Health and Social Care said it hoped to improve compliance and timeliness of shortage reporting.…
Investigational anti-clotting drug reduced stroke risk by more than one-quarter, study finds Researchers observed a 17% reduction in major cardiovascular events in patients who took asundexian compared with the placebo group.…
Amyloid-targeting Alzheimer’s drugs ‘probably’ not effective Authors of a Cochrane review said that any effect that donanemab and lecanemab have on cognitive function and dementia severity at 18 months was “trivial”.…
Paul Bennett and Karen Baxter: ‘15 April 2026 isn’t the end of this story — it’s just the foundation stone’ As the Royal Pharmaceutical Society transitions to become the Royal College of Pharmacy, The Pharmaceutical Journal spoke to Paul Bennett and Karen Baxter about their reflections on and hopes for the change.…
Royal College of Pharmacy now established in ‘defining moment’ for profession Pharmacy leaders have called the transition an “opportunity to create a genuinely ambitious, modern and inclusive institution, benefiting the whole of pharmacy”.…
